Integrin-mediated drug targeting
v3 v3 The present invention relates to cytostatics which have a tumour-specific action as a result of linkage to αβintegrin antagonists via preferred linking units. The preferred linking units guarantee serum stability of the conjugate of cytostatic and αβintegrin antagonist and at the same time the...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!